1. Home
  2. MNKD vs TASK Comparison

MNKD vs TASK Comparison

Compare MNKD & TASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • TASK
  • Stock Information
  • Founded
  • MNKD 1991
  • TASK 2008
  • Country
  • MNKD United States
  • TASK United States
  • Employees
  • MNKD N/A
  • TASK N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • TASK Retail: Computer Software & Peripheral Equipment
  • Sector
  • MNKD Health Care
  • TASK Technology
  • Exchange
  • MNKD Nasdaq
  • TASK Nasdaq
  • Market Cap
  • MNKD 1.6B
  • TASK 1.5B
  • IPO Year
  • MNKD 2004
  • TASK 2021
  • Fundamental
  • Price
  • MNKD $5.03
  • TASK $13.63
  • Analyst Decision
  • MNKD Buy
  • TASK Buy
  • Analyst Count
  • MNKD 6
  • TASK 7
  • Target Price
  • MNKD $8.92
  • TASK $18.14
  • AVG Volume (30 Days)
  • MNKD 1.9M
  • TASK 321.2K
  • Earning Date
  • MNKD 05-07-2025
  • TASK 05-07-2025
  • Dividend Yield
  • MNKD N/A
  • TASK N/A
  • EPS Growth
  • MNKD N/A
  • TASK 4.17
  • EPS
  • MNKD 0.10
  • TASK 0.50
  • Revenue
  • MNKD $285,504,000.00
  • TASK $994,985,000.00
  • Revenue This Year
  • MNKD $14.66
  • TASK $14.37
  • Revenue Next Year
  • MNKD $14.27
  • TASK $9.49
  • P/E Ratio
  • MNKD $50.50
  • TASK $27.40
  • Revenue Growth
  • MNKD 43.50
  • TASK 7.64
  • 52 Week Low
  • MNKD $3.97
  • TASK $10.56
  • 52 Week High
  • MNKD $7.63
  • TASK $19.60
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 37.28
  • TASK 45.32
  • Support Level
  • MNKD $5.16
  • TASK $13.33
  • Resistance Level
  • MNKD $5.12
  • TASK $13.94
  • Average True Range (ATR)
  • MNKD 0.14
  • TASK 0.40
  • MACD
  • MNKD 0.01
  • TASK 0.12
  • Stochastic Oscillator
  • MNKD 25.45
  • TASK 60.85

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About TASK TaskUs Inc.

TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to inventive and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.

Share on Social Networks: